You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED (D.N.J. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-04-05 103 various patents covering Baxter’s esmolol hydrochloride product, U.S. Patent Nos. 6,310,094 (hereinafter…hereinafter, “’094 Patent”) and 6,528,540 (hereinafter, “’540 Patent” and collectively, the “patents-in-suit” …subject matter to the patents-in- suit. (Compare ’094 Patent at 6:1-9, with ’540 Patent at 2:20- 29.) …reference to the ’540 Patent, U.S. Patent No. 5,017,609 (mistakenly referred as U.S. Patent No. 5,107,609) …Definition Embodied in the ’540 Patent Carries to the ’094 Patent ................................ External link to document
2015-08-19 61 Certificate of Service Attachments: # 1 Exhibit A - U.S. Patent No. 6,310,094, # 2 Exhibit B - U.S. Patent No. 6,528,540, # 3 Certificate…2014 20 April 2016 1:14-cv-07094 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.